FEATURE: Gene Editing | Townsquare | KeyW | Salem | Energy Fuels | Gene Therapy…


CRISPR-Cas9: The Gene-Editing Tool That Could Fix Disease and Eradicate Cancer.
Is CRISPR-Cas9 the most influential scientific discovery of our generation? More 

Townsquare Media (TSQ) A Premium Valuation Appears Warranted. More

KeyW Holding Corporation (KEYW) Are needle moving contracts on the horizon. More

Salem Media Group (SALM) Why Investors Should Look Past The Soft Q1 Guidance. More

Energy Fuels (UUUU) Focusing On Vanadium Until Uranium Markets Improve; Trump To The Rescue? More


Making Profits, Saving Lives With Gene Therapy. After thirty years of development, gene therapy is seeing a surge of progress and profitability. Genprex Inc. (GNPX), Dyadic International Inc (DYAI), TrovaGene Inc. (TROV) and others… More 

TrovaGene, Inc. (TROV) , a clinical-stage, oncology therapeutics company, receives approximately $3.0 Million from exercise of warrants. More

Salem Media Group, Inc. (SALM), multimedia company specializing in Christian and conservative content, announces fourth quarter 2018 total revenue of $67.2 Million. More

Leave a Reply